HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-JAN-13 4IWD TITLE STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX TITLE 2 WITH AN MK-8033 ANALOG COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1048-1348; COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET KEYWDS PROTEIN KINASE, TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.M.SOISSON,A.NORTHRUP,K.RICKERT,S.PATEL,T.ALLISON REVDAT 2 15-NOV-17 4IWD 1 REMARK REVDAT 1 11-DEC-13 4IWD 0 JRNL AUTH A.B.NORTHRUP,M.H.KATCHER,M.D.ALTMAN,M.CHENARD,M.H.DANIELS, JRNL AUTH 2 S.V.DESHMUKH,D.FALCONE,D.J.GUERIN,H.HATCH,C.LI,W.LU, JRNL AUTH 3 B.LUTTERBACH,T.J.ALLISON,S.B.PATEL,J.F.REILLY,M.REUTERSHAN, JRNL AUTH 4 K.W.RICKERT,C.ROSENSTEIN,S.M.SOISSON,A.A.SZEWCZAK,D.WALKER, JRNL AUTH 5 K.WILSON,J.R.YOUNG,B.S.PAN,C.J.DINSMORE JRNL TITL DISCOVERY OF JRNL TITL 2 1-[3-(1-METHYL-1H-PYRAZOL-4-YL)-5-OXO-5H-BENZO[4, JRNL TITL 3 5]CYCLOHEPTA[1,2-B]PYRIDIN-7-YL]-N-(PYRIDIN-2-YLMETHYL) JRNL TITL 4 METHANESULFONAMIDE (MK-8033): A SPECIFIC C-MET/RON DUAL JRNL TITL 5 KINASE INHIBITOR WITH PREFERENTIAL AFFINITY FOR THE JRNL TITL 6 ACTIVATED STATE OF C-MET. JRNL REF J.MED.CHEM. V. 56 2294 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23379595 JRNL DOI 10.1021/JM301619U REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 19939 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1019 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2675 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2075 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2533 REMARK 3 BIN R VALUE (WORKING SET) : 0.2029 REMARK 3 BIN FREE R VALUE : 0.2871 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.31 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2432 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 106 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.79880 REMARK 3 B22 (A**2) : -6.06160 REMARK 3 B33 (A**2) : 7.86040 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.243 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.211 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2539 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3445 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 849 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 8.000 ; HARMONIC REMARK 3 GENERAL PLANES : 365 ; 8.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2539 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 311 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3020 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.36 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IWD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077292. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20043 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.40700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15.6 MG/ML PROTEIN MIXED IN 1:1 RATIO REMARK 280 WITH RESERVOIR CONTAINING 150 MM MALIC ACID, 20% PEG3350, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.06700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.21750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.89450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.21750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.06700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.89450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A1173 -71.17 -66.30 REMARK 500 ASN A1175 61.49 31.84 REMARK 500 ARG A1203 -13.84 72.01 REMARK 500 TYR A1230 -107.99 55.89 REMARK 500 HIS A1238 -57.52 -123.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1JC A 1401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3R7O RELATED DB: PDB REMARK 900 STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX REMARK 900 WITH AN MK-2461 ANALOG DBREF 4IWD A 1048 1348 UNP P08581 MET_HUMAN 1048 1348 SEQADV 4IWD AME A 1047 UNP P08581 EXPRESSION TAG SEQADV 4IWD HIS A 1349 UNP P08581 EXPRESSION TAG SEQADV 4IWD HIS A 1350 UNP P08581 EXPRESSION TAG SEQADV 4IWD HIS A 1351 UNP P08581 EXPRESSION TAG SEQADV 4IWD HIS A 1352 UNP P08581 EXPRESSION TAG SEQRES 1 A 306 AME GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN SEQRES 2 A 306 PRO GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY SEQRES 3 A 306 PRO SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY SEQRES 4 A 306 ARG GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU SEQRES 5 A 306 ASP ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER SEQRES 6 A 306 LEU ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE SEQRES 7 A 306 LEU THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO SEQRES 8 A 306 ASN VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU SEQRES 9 A 306 GLY SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY SEQRES 10 A 306 ASP LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO SEQRES 11 A 306 THR VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA SEQRES 12 A 306 LYS GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS SEQRES 13 A 306 ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS SEQRES 14 A 306 PHE THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP SEQRES 15 A 306 MET TYR ASP LYS GLU PTR PTR SER VAL HIS ASN LYS THR SEQRES 16 A 306 GLY ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER SEQRES 17 A 306 LEU GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SEQRES 18 A 306 SER PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY SEQRES 19 A 306 ALA PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR SEQRES 20 A 306 VAL TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU SEQRES 21 A 306 TYR CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS SEQRES 22 A 306 TRP HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU SEQRES 23 A 306 LEU VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE SEQRES 24 A 306 GLY GLU HIS HIS HIS HIS HIS MODRES 4IWD PTR A 1234 TYR O-PHOSPHOTYROSINE MODRES 4IWD PTR A 1235 TYR O-PHOSPHOTYROSINE HET AME A1047 11 HET PTR A1234 16 HET PTR A1235 16 HET 1JC A1401 39 HETNAM AME N-ACETYLMETHIONINE HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1JC 1-{5-OXO-3-[1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL]-5H- HETNAM 2 1JC BENZO[4,5]CYCLOHEPTA[1,2-B]PYRIDIN-7-YL}-N-(PYRIDIN-2- HETNAM 3 1JC YLMETHYL)METHANESULFONAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 AME C7 H13 N O3 S FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 1JC C29 H28 N6 O3 S FORMUL 3 HOH *106(H2 O) HELIX 1 1 AME A 1047 VAL A 1051 5 5 HELIX 2 2 ASP A 1054 LEU A 1058 5 5 HELIX 3 3 ASN A 1059 VAL A 1069 1 11 HELIX 4 4 GLY A 1072 SER A 1074 5 3 HELIX 5 5 ASP A 1117 ILE A 1130 1 14 HELIX 6 6 LEU A 1165 ASN A 1171 1 7 HELIX 7 7 THR A 1177 LYS A 1198 1 22 HELIX 8 8 ALA A 1206 ARG A 1208 5 3 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ASN A 1288 PHE A 1290 5 3 HELIX 13 13 ASP A 1291 GLN A 1298 1 8 HELIX 14 14 PRO A 1309 TRP A 1320 1 12 HELIX 15 15 LYS A 1323 ARG A 1327 5 5 HELIX 16 16 SER A 1329 PHE A 1344 1 16 SHEET 1 A 5 LEU A1076 ARG A1086 0 SHEET 2 A 5 CYS A1091 LEU A1098 -1 O VAL A1092 N ILE A1084 SHEET 3 A 5 LYS A1104 SER A1111 -1 O ILE A1105 N LEU A1097 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 B 3 GLY A1163 ASP A1164 0 SHEET 2 B 3 CYS A1210 LEU A1212 -1 O LEU A1212 N GLY A1163 SHEET 3 B 3 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 C 2 PHE A1200 VAL A1201 0 SHEET 2 C 2 ARG A1227 ASP A1228 -1 O ARG A1227 N VAL A1201 SHEET 1 D 2 PTR A1235 SER A1236 0 SHEET 2 D 2 LYS A1259 PHE A1260 -1 O PHE A1260 N PTR A1235 LINK C AME A1047 N GLN A1048 1555 1555 1.35 LINK C GLU A1233 N PTR A1234 1555 1555 1.33 LINK C PTR A1234 N PTR A1235 1555 1555 1.31 LINK C PTR A1235 N SER A1236 1555 1555 1.35 SITE 1 AC1 22 ILE A1084 GLY A1085 ARG A1086 GLY A1087 SITE 2 AC1 22 HIS A1088 VAL A1092 ALA A1108 PRO A1158 SITE 3 AC1 22 TYR A1159 MET A1160 LYS A1161 GLY A1163 SITE 4 AC1 22 ARG A1208 ASN A1209 MET A1211 ALA A1221 SITE 5 AC1 22 ASP A1222 GLN A1304 HOH A1510 HOH A1528 SITE 6 AC1 22 HOH A1560 HOH A1585 CRYST1 40.134 63.789 112.435 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024917 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015677 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008894 0.00000 HETATM 1 CT2 AME A1047 -0.502 -11.999 15.040 1.00 28.35 C HETATM 2 CT1 AME A1047 -0.157 -11.237 13.764 1.00 25.75 C HETATM 3 OT AME A1047 -0.099 -9.941 13.403 1.00 20.22 O HETATM 4 CB AME A1047 0.978 -13.388 11.193 1.00 31.88 C HETATM 5 CG AME A1047 2.467 -13.736 11.576 1.00 38.48 C HETATM 6 SD AME A1047 3.641 -12.233 11.419 1.00 45.08 S HETATM 7 CE AME A1047 3.748 -12.111 9.558 1.00 42.97 C HETATM 8 C AME A1047 -0.747 -11.557 10.791 1.00 27.63 C HETATM 9 O AME A1047 -1.882 -11.816 11.207 1.00 24.95 O HETATM 10 N AME A1047 0.118 -12.290 13.001 1.00 25.64 N HETATM 11 CA AME A1047 0.484 -11.966 11.624 1.00 26.41 C